As a result, multi-step theories of fibrosis mechanism in SSc patients have been proposed: TGF-β begins fibrosis, and ET-1/CTGF acts in the maintenance process, and Ras-MEK-ERK1/2 pathways amplify persistent it (Fig. 3). This evidence concerns the gene CCN2 and systemic sclerosis.